Overview
Satoshi Ebata practices in Tokyo, Japan. Mr. Ebata is rated as a Distinguished expert by MediFind in the treatment of Scleroderma. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Acute Interstitial Pneumonia, and Interstitial Lung Disease.
His clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 27 articles in the study of Scleroderma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SclerodermaMr. Ebata isDistinguished. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Mr. Ebata isDistinguished. Learn about Systemic Sclerosis (SSc).
- Advanced
- Acute Interstitial PneumoniaMr. Ebata isAdvanced. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseMr. Ebata isAdvanced. Learn about Interstitial Lung Disease.
- Experienced
- AcrospiromaMr. Ebata isExperienced. Learn about Acrospiroma.
- Necrotizing VasculitisMr. Ebata isExperienced. Learn about Necrotizing Vasculitis.
- Polyarteritis NodosaMr. Ebata isExperienced. Learn about Polyarteritis Nodosa.
- Pulmonary FibrosisMr. Ebata isExperienced. Learn about Pulmonary Fibrosis.
- Syringocystadenoma PapilliferumMr. Ebata isExperienced. Learn about Syringocystadenoma Papilliferum.
- VasculitisMr. Ebata isExperienced. Learn about Vasculitis.